Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Tickers ABBV ADBE ADSK AKAM
Tags FCNCA LNTH WOOF
From Benzinga
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
Tickers ALNY AZN IONS NVS
Tags General IONS Contracts
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags BZI/AAR Market News Analyst Ratings
From Benzinga
Why Ionis Pharmaceuticals Stock Popped Today
Tickers IONS
Tags Benzinga IONS why it's moving
From Benzinga
Ionis Pharmaceuticals' Rare Metabolic Disorder Candidate Poised To Become New Standard Treatment, Study Shows Encouraging Action
Tickers IONS
Tags Market News Movers Biotech
From Benzinga
The 7 Most Hated Stocks by Institutional Traders
Tickers GS IONS LLY PDD
Tags PTON Market News PDD
From InvestorPlace
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
Tickers ALNY IONS RHHBF RHHBY
Tags RHHBY Biotech Expert Ideas
From Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Tickers ACCD ARKG ARKK ARKW
Tags ARKG Equities PACB
From Benzinga
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
Tickers ALNY AZN IONS
Tags Analyst Ratings Upgrades General
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Tickers A ABR ADBE AIV
Tags PAG ABR AVTR
From Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
Tickers AAPL ADBE BAX CMCSA
Tags BAX Benzinga GTLS
From Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
Tickers BIIB IONS NVS
Tags Benzinga BIIB IONS
From Benzinga
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
Tickers IONS NTLA
Tags Analyst Ratings General IONS
From Benzinga
Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway'
Tickers AZN IONS
Tags Health Care Trading Ideas News
From Benzinga
Why Ionis Pharmaceutical Shares Are Trading Lower Wednesday
Tickers IONS
Tags Market News why it's moving News
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Tickers ABSI BLDR BLKB CERE
Tags BLKB BZI/Ratings Benzinga
From Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
Tickers IONS
Tags Earnings Market News IONS
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags Earnings Market News BZI/EP
From Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
Tickers BIIB IONS
Tags FDA Biotech Market News
From Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
Tickers BIIB IONS
Tags BIIB IONS
From MarketWatch
What's Going On With Biogen Stock Tuesday?
Tickers BIIB IONS
Tags Market News Earnings FDA
From Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
Tickers BIIB IONS
Tags News General IONS
From Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
Tickers ACRS AMRS IONS
Tags AMRS NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS Market News
From InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
Tickers AZN AZNCF IONS
Tags Market News Biotech AZN
From Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Tickers AZN IONS
Tags IONS Recent Press Releases AZN
From Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
Tickers ALNY ARWR IONS MRNA
Tags Price Target Expert Ideas Biotech
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Tickers AZN AZNCF BXRX IONS
Tags News General Benzinga
From Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
Tickers BIIB IONS
Tags Briefs FDA Biotech
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.